Seeing Is Believing
BCAB is currently covered by 6 analysts with an average price target of $13.11. This is a potential upside of $10.76 (457.87%) from yesterday's end of day stock price of $2.35.
Bioatla 's activity chart (see below) currently has 8 price targets and 24 ratings on display. The stock rating distribution of BCAB is 82.35% BUY and 17.65% HOLD.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 12.14 days.
Highest price target for BCAB is $12, Lowest price target is $12, average price target is $13.11.
Most recent stock forecast was given by RENI BENJAMIN from JMP on 28-Mar-2024.
Currently out of the existing stock ratings of BCAB, 14 are a BUY (82.35%), 3 are a HOLD (17.65%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
$9.65 (410.64%)
12
28 days ago
0/5 (0%)
$8.56 (248.84%)
Buy
87
1 years 28 days ago
1/2 (50%)
$29.63 (51.65%)
14
Hold
8
$5.65 (240.43%)
8
1 years 1 months 1 days ago
4/6 (66.67%)
$5.64 (238.98%)
71
Buy
20
$17.65 (751.06%)
25
1 years 8 months 15 days ago
0/2 (0%)
$13.39 (202.57%)
Buy
64
2 years 5 months 7 days ago
0/1 (0%)
$18.11 (39.46%)
What is BCAB (Bioatla ) average time for price targets to be met?
Which analyst has the current highest performing score on BCAB (Bioatla ) with a proven track record?
Which analyst has the current lower performing score on BCAB (Bioatla ) with a proven track record?
Which analyst has the most public recommendations on BCAB (Bioatla )?
Which analyst is the currently most bullish on BCAB (Bioatla )?
Which analyst is the currently most reserved on BCAB (Bioatla )?